DexCom DXCM Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $836.3M+45.1% | $576.2M+6.4% | $541.5M+58.7% | $341.2M+53.6% | ||
| $251.8M+15.7% | $217.7M+17.0% | $186M+19.3% | $155.9M+52.8% | ||
| $159.6M-6.3% | $170.4M+13.0% | $150.8M+19.2% | $126.5M+11.6% | ||
| $182.2M— | —— | —— | —— | ||
| —— | $35M-86.5% | $260.1M+30.1% | $199.9M— | ||
| $63.7M+614% | -$12.4M-105% | $252.6M+612% | -$49.3M-144% | ||
| —— | $231.7M-53.3% | $496.5M+68.2% | $295.1M— | ||
| $56.6M— | —— | $37.2M— | —— | ||
| $14.8M— | —— | -$19.3M— | —— | ||
| -$11.5M-36.9% | -$8.4M-223% | -$2.6M— | —— | ||
| —— | —— | $83.9M+343% | -$34.5M+20.9% | ||
| —— | —— | —— | $200K-98.3% | ||
| $1.44B+45.6% | $989.5M+32.2% | $748.5M+11.8% | $669.5M+51.3% | ||
| $363.5M+1.3% | $358.8M+51.6% | $236.6M-35.1% | $364.8M-6.3% | ||
| $1.25B-51.6% | $2.58B-19.5% | $3.2B+41.2% | $2.27B-8.4% | ||
| $2.16B-23.4% | $2.82B-4.2% | $2.95B+38.5% | $2.13B-20.2% | ||
| -$600K-104% | $15.5M+916% | -$1.9M-850% | -$200K+98.0% | ||
| —— | -$207.5M— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| -$7M+46.2% | -$13M-967% | $1.5M+109% | -$17.3M-74.7% | ||
| -$1.69B-130% | -$734.8M-131% | -$318.6M+42.3% | -$552.5M— | ||
| $22.6M+405% | -$7.4M-593% | $1.5M— | —— | ||
| —— | —— | -$75.8M+82.4% | -$429.6M— | ||
| $11.4M0.0% | $11.4M-8.1% | $12.4M+1.6% | $12.2M+5.2% | ||
| $94.4M-52.3% | $198M-6.7% | $212.3M+85.9% | $114.2M+580% | ||
| —— | —— | —— | —— | ||
| $56.6M— | —— | $37.2M— | —— | ||
| $7.1M— | —— | $4.5M— | —— | ||
| $14.8M— | —— | -$19.3M— | —— | ||
| —— | —— | $83.9M+343% | -$34.5M+20.9% | ||
| $7.3M-2.7% | $7.5M-3.8% | $7.8M+23.8% | $6.3M-12.5% | ||
| -$600K-104% | $15.5M+916% | -$1.9M-850% | -$200K+98.0% | ||
| —— | —— | $19.5M+34.5% | $14.5M— | ||
| $2.16B-23.4% | $2.82B-4.2% | $2.95B+38.5% | $2.13B-20.2% | ||
| -$7M+46.2% | -$13M-967% | $1.5M+109% | -$17.3M-74.7% | ||
| $1.21B— | $0— | $0— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| $1.08B+70.8% | $630.7M+23.2% | $511.9M+68.0% | $304.7M+472% | ||
| $1.08B+70.8% | $630.7M+23.2% | $511.9M+68.0% | $304.7M+472% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does DexCom generate?
- DexCom (DXCM) generated $1.8B in operating cash flow over the trailing twelve months.
- What is DexCom's free cash flow?
- After $353.1M of capital expenditures, DexCom's free cash flow was $1.4B over the trailing twelve months, up 148.5% year over year.
- Where does DexCom's cash flow data come from?
- Every line is extracted from DexCom's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
